Browse Items (4 total)
- Tags: Benzodiazepine
Racial and Ethnic Disparities in End-of-Life Care of Children Undergoing Terminal Extubation in ICU
Tags: 2024, Adult, Age Distribution, Aged, airway pressure, Benzodiazepine, Burkiewicz K, Caucasian, Child, conference abstract, Critical Care Medicine, electronic medical record, ethnic difference, Ethnic Group, Ethnicity, extubation, Female, Hispanic, Human, hypertensive factor, Intensive Care, Intensive Care Unit, July List 2024, Major Clinical Study, Male, Morphine, Only Child, Pediatric Intensive Care Unit, positive end expiratory pressure ventilation, positive pressure ventilation, racial disparity, Secondary Analysis, Terminal Care, Tripathi S, ventilator, Winter M
Medication utilization for symptom management by pediatric inpatients with cancer at end-of-life
Tags: 2019, Adult, anxiety, Benzodiazepine, Black person, Cancer Patient, Child, Childhood Cancer, conference abstract, Controlled Study, Davidoff A, Death, Decision Making, do not resuscitate order, Drug Therapy, Ethnicity, Female, Gender, Hospital Patient, Hospitalization, Human, Length Of Stay, Major Clinical Study, Male, manager, Massaro S, Medicaid, Multicenter Study, Nausea, Oncology 2019 List, Opiate, Pain, patient history of bone marrow transplantation, Pediatric Blood and Cancer, pediatric patient, Prozora S, Recipient, Retrospective Study, Shabanova V, solid malignant neoplasm, tumor diagnosis, University Hospital, Young Adult
Benzodiazepine dependence and withdrawal: a review of the syndrome and its clinical management
Tags: 1998, Acta Psychiatrica Scandinavica, Supplementum, Animal, Anti-Anxiety Agents, Anxiety Disorders/dt [Drug Therapy], Anxiety Disorders/px [Psychology], Backlog, Benzodiazepine, Benzodiazepine/ae [Adverse Effects], Benzodiazepine/tu [Therapeutic Use], Human, Journal Article, Rickels K, Schweizer E, Substance Withdrawal Syndrome/di [Diagnosis], Substance Withdrawal Syndrome/rh [Rehabilitation], Substance-Related Disorders/di [Diagnosis], Substance-Related Disorders/rh [Rehabilitation], Syndrome, Treatment Outcome
Palliative Care
Tags: 103-90-2 (paracetamol), 1095-90-5 (methadone), 125-56-4 (methadone), 12794-10-4 (benzodiazepine), 137-58-6 (lidocaine), 2017, 23142-53-2 (methadone), 24847-67-4 (lidocaine), 297-88-1 (methadone), 437-38-7 (fentanyl), 53663-61-9 (opiate), 56934-02-2 (lidocaine), 60142-96-3 (gabapentin), 73-78-9 (lidocaine), 76-99-3 (methadone), 8002-76-4 (opiate), 8008-60-4 (opiate), Acute Stress Disorder, Alcohol Consumption, Anticonvulsive Agent, Appetite, Benzodiazepine, Brill P, Connelly E, Corticosteroid, Distress Syndrome, Dyspnea, Fentanyl, Gabapentin, Hair Loss, Health Care Personnel, Health Care System, Hospital, Howk T, Human, Intensive Care Unit, Lidocaine, Major Depression, Medical Staff, Methadone, Mortality, Nausea And Vomiting, Neoplasm, November 2017 List, Obesity, Opiate, Palliative Therapy, Paracetamol, Paralysis, Patient Care Planning, Pediatric Oncology, Pillai R, Postovsky S, Priority Journal, Prostaglandin/ec [endogenous Compound], Quality Of Life, Tracheostomy, Wasilewski-Masker K, Wrammert KC